Drug companies will stop a cure hitting the market
Collapse
X
-
sorry to detract from your point (something gmanaco practises)
but I spend £40 a month on propecia
£20 a month on rogaine
£30 a month on couvre
£6 a month on Nizoral
that is £96 a month x 12 = £1152! in todays dollars this is actually $1827.
back to your point that there are a couple of companies competing and they all make soo much more money out of other products etc so why would they bother interfering ... well dont forget that each of these companies will not look at their finances as a whole and be like oh let's just forget about controlling the hairloss market because we have plenty of other products etc they will all meticulously work out the best way to make sales and profits out of each product that they sell and as I pointed out their customers with the long term treatment products are worth more than they could get away charging for a one off cure treatment. I rest my case, thanks for playing though.Leave a comment:
-
-
WHO? Who are the big guys?? Merck and Johnson&Johnson are SEPARATE COMPANIES. THEY COMPETE WITH EACH OTHER. Why should Merck spend billions of dollars buying Replicel to also preserve Rogaine's profit??yes, if replicel came up with a cure, the big guys with vested interests in propecia, rogaine etc would buy them out or buy the patent off them. to get all the people who would otherwise be on the big 3 to go out and spend money on a cure.. the market price would have to be as low as $20,000 i think that's a probably high estimate but anyway... now someone like me who uses $1600 hairloss products a year is worth a lot more to them (roughly $50,000) assuming i continue with treatment until I am 50 yrs old so its a no brainer to them, keep the one off cure out of the market as it equals over 50% reduction in profits
also: No one spends $1600 on hair loss per year.... Most people spend much much less and a lot of them buy generics (Merck makes no money off of that). Propecia's patent is about to expire anyways. I guarantee you, Merck does not give a shit about Propecia. They make > 95% of their profits from their other drugs anyways.
Take your conspiracy crap someplace else.Leave a comment:
-
As has already been pointed out repeatedly, minoxidil's patent has expired, and finasteride's will expire next year. No one company makes enough off of either of those products to make it economically viable for them to buy up patents and companies to keep a more effective treatment off the market, or even to want to.
It's so sad to see kids growing up these days without a basic grasp of mathematics.the market price would have to be as low as $20,000 i think that's a probably high estimate but anyway... now someone like me who uses $1600 hairloss products a year is worth a lot more to them (roughly $50,000) assuming i continue with treatment until I am 50 yrs old so its a no brainer to them, keep the one off cure out of the market as it equals over 50% reduction in profitsLeave a comment:
-
-
a broken clock is still right twice a day my friendThat's just absurd. No one company is such a big player in the hair loss market that by pursuing such a strategy they wouldn't end up spending as much money buying up all those patents and companies then they were taking in from sales of their existing hair loss treatments.Leave a comment:
-
yes, if replicel came up with a cure, the big guys with vested interests in propecia, rogaine etc would buy them out or buy the patent off them. to get all the people who would otherwise be on the big 3 to go out and spend money on a cure.. the market price would have to be as low as $20,000 i think that's a probably high estimate but anyway... now someone like me who uses $1600 hairloss products a year is worth a lot more to them (roughly $50,000) assuming i continue with treatment until I am 50 yrs old so its a no brainer to them, keep the one off cure out of the market as it equals over 50% reduction in profitswhat?? Wouldn't they LOSE money since they spent so much of it on research and development for that particular treatment??
no they get given the money for the patent, or they get bought out by Johnson & Johnson etc
what are you trying to say??? If Replicel came up with a cure, someone would buy it out in order to keep that treatment off the market? WHY!!?!Leave a comment:
-
That's just absurd. No one company is such a big player in the hair loss market that by pursuing such a strategy they wouldn't end up spending as much money buying up all those patents and companies then they were taking in from sales of their existing hair loss treatments.Leave a comment:
-
what?? Wouldn't they LOSE money since they spent so much of it on research and development for that particular treatment??
what are you trying to say??? If Replicel came up with a cure, someone would buy it out in order to keep that treatment off the market? WHY!!?!When they are successful and create a real promising treatment that looks like a cure, a bigger player comes in and buys them out either by giving them money for the patent or buy buying the company out. I am not saying this is always going to be the case but I believe its happening often and is a result of the greedy capitalist system and its exploitation of the medical industry.Leave a comment:
-
It does not take a genius to realise drug companies make money out of creating treatments whether or not they come to market. This is the reason they do spend money and genuinely try to come up with stuff. You see curing baldness and making money from curing baldness are not the same thing.
When they are successful and create a real promising treatment that looks like a cure, a bigger player comes in and buys them out either by giving them money for the patent or buy buying the company out. I am not saying this is always going to be the case but I believe its happening often and is a result of the greedy capitalist system and its exploitation of the medical industry.Leave a comment:
-
read my latest post.and gmonanco, we'll have to agree to disagree, sorry if you found that offensive. I am not going to waste any more time arguing with someone who, in my opinion at least, is desperate to ignore the bigger picture. For the record i hope i am wrong just like the rest of us would like to see baldness be a thing of the past
It simply makes no sense for anyone to spend billions of dollars to prevent the hair loss cure from coming into the market.
You lost this argument. Thanks for playing.Leave a comment:
-
come on where's your sense of humour, i'm hardly trolling.
and gmonanco, we'll have to agree to disagree, sorry if you found that offensive. I am not going to waste any more time arguing with someone who, in my opinion at least, is desperate to ignore the bigger picture. for the record I hope I am wrong just like the rest of us would like to see baldness be a thing of the pastLeave a comment:
-
Or anybody else. The pharmaceutical industry isn't one monolithic entity; it's a group of multiple, competing companies. Even if Company X doesn't want to see a hair loss cure on the market because it might cut into sales of one of their existing products, there's no motivation for every other pharmaceutical company to act similarly. They'd all love to put out something that would stomp all over a competitor's product.Leave a comment:
-
exactly....
This is what makes Merck money:
singulair: 3.5 billion
Cozaar, Hyzaar: 3.1 billion
Fosamax: 3.1 billion
Zocor : 2.8 billion
.....
do you think Merck even cares about their 400 million ( 3% from their total profits if only you were to count those 4 products I've listed) from Propecia whose sales will certainly crash in 2013 after its patent expires.
So there you have it: IT MAKES NO FINANCIAL SENSE for Merck to buy up all those companies that have the cure for hair loss.Leave a comment:
Leave a comment: